Open AccessAdvanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
Author(s) -
Evelyn Nunes Goulart da Silva Pereira,
Daniela Polessa Paula,
Beatriz Peres de Araujo,
Maria de Jesus Mendes da Fonseca,
Maria de Fátima Haueisen Sander Diniz,
Anissa Daliry,
Rosane Härter Griep
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i29.4913
Subject(s) - fatty liver , biomarker , medicine , alcoholic liver disease , disease , glycation , gastroenterology , chemistry , biochemistry , cirrhosis , receptor
Liver diseases are associated with the excess formation of advanced glycation end products (AGEs), which induce tissue inflammation and oxidative damage. However, the trend of oxidative marker levels according to the steatosis grade in non-alcoholic fatty liver disease (NAFLD) is unclear.